PF-06273340

PF-06273340 Uses, Dosage, Side Effects, Food Interaction and all others data.

Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)).

Trade Name PF-06273340
Generic PF-06273340
Type
Formula C23H22ClN7O3
Weight Average: 479.93
Monoisotopic: 479.1472653
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PF-06273340
PF-06273340

Innovators Monograph

You find simplified version here PF-06273340

*** Taking medicines without doctor's advice can cause long-term problems.
Share